SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-09-025503
Filing Date
2009-05-11
Accepted
2009-05-11 17:24:48
Documents
10
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 v148794_10q.htm 10-Q 690000
2 v148794_ex1-1.htm EX-1.1 39141
3 v148794_ex4-1.htm EX-4.1 110243
4 v148794_ex4-2.htm EX-4.2 104395
5 v148794_ex10-1.htm EX-10.1 232669
6 v148794_ex31-1.htm EX-31.1 17094
7 v148794_ex31-2.htm EX-31.2 16952
8 v148794_ex32-1.htm EX-32.1 6524
9 v148794_ex32-2.htm EX-32.2 6274
10 v148794_ex99-1.htm EX-99.1 8695
  Complete submission text file 0001144204-09-025503.txt   1233449
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13441 | Film No.: 09816350
SIC: 2836 Biological Products, (No Diagnostic Substances)